Cargando…
Association of tamoxifen resistance and lipid reprogramming in breast cancer
BACKGROUND: Tamoxifen treatment of estrogen receptor (ER)-positive breast cancer reduces mortality by 31%. However, over half of advanced ER-positive breast cancers are intrinsically resistant to tamoxifen and about 40% will acquire the resistance during the treatment. METHODS: In order to explore m...
Autores principales: | Hultsch, Susanne, Kankainen, Matti, Paavolainen, Lassi, Kovanen, Ruusu-Maaria, Ikonen, Elina, Kangaspeska, Sara, Pietiäinen, Vilja, Kallioniemi, Olli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109356/ https://www.ncbi.nlm.nih.gov/pubmed/30143015 http://dx.doi.org/10.1186/s12885-018-4757-z |
Ejemplares similares
-
Reanalysis of RNA-Sequencing Data Reveals Several Additional Fusion Genes with Multiple Isoforms
por: Kangaspeska, Sara, et al.
Publicado: (2012) -
Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer
por: Kangaspeska, Sara, et al.
Publicado: (2016) -
Regression plane concept for analysing continuous cellular processes with machine learning
por: Szkalisity, Abel, et al.
Publicado: (2021) -
The impact of RNA sequence library construction protocols on transcriptomic profiling of leukemia
por: Kumar, Ashwini, et al.
Publicado: (2017) -
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
por: Blom, Sami, et al.
Publicado: (2017)